Relevant bibliographies by topics / 2010 ACR/EULAR

Contents

  1. Journal articles
  2. Book chapters
  3. Conference papers

Academic literature on the topic '2010 ACR/EULAR'

Author: Grafiati
Published: 5 June 2025
Last updated: 24 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '2010 ACR/EULAR.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "2010 ACR/EULAR"

1

Kay, J., and K. S. Upchurch. "ACR/EULAR 2010 rheumatoid arthritis classification criteria." Rheumatology 51, suppl 6 (2012): vi5—vi9. http://dx.doi.org/10.1093/rheumatology/kes279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

VARACHE, SOPHIE, DIVI CORNEC, JOHANNE MORVAN, et al. "Diagnostic Accuracy of ACR/EULAR 2010 Criteria for Rheumatoid Arthritis in a 2-Year Cohort." Journal of Rheumatology 38, no. 7 (2011): 1250–57. http://dx.doi.org/10.3899/jrheum.101227.

Full text
Abstract:
Objective.To evaluate the diagnostic accuracy of the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) and 1987 ACR criteria for rheumatoid arthritis (RA), and the respective role of the algorithm and scoring of the ACR/EULAR.Methods.In total, 270 patients with recent-onset arthritis of < 1 year duration were included prospectively between 1995 and 1997 and followed for 2 years. RA was defined as the combination, at completion of followup, of RA diagnosed by an office-based rheumatologist and treatment with a disease-modifying antirheumatic drug or glucocorticoid. We compared the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the criteria sets in the overall population, in the subgroup meeting the tree condition for ACR/EULAR scoring, and in the overall population classified according the full tree.Results.At baseline, 111 of the 270 patients had better alternative diagnoses and 16 had erosions typical for RA; of the 143 remaining patients, 52 had more than 6 ACR/EULAR 2010 points (indicating definite RA) and 91 had fewer than 6 points. After 2 years, 11/16 patients with erosions and 40/52 with more than 6 points had RA. 100 of the 270 patients met the reference standard for RA. Sensitivity, specificity, PPV, and NPV of the ACR/EULAR (full tree) were 51/100 (51%), 153/170 (90%), 51/68 (75.4%), and 153/202 (75.7%), respectively. Diagnostic accuracies of the ACR/EULAR score and ACR 1987 criteria were not statistically different.Conclusion.Much of the improvement of the ACR/EULAR criteria was ascribable to the use of exclusion criteria in the algorithm.
APA, Harvard, Vancouver, ISO, and other styles
3

Harigai, Masayoshi. "1. 2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis." Nihon Naika Gakkai Zasshi 101, no. 10 (2012): 2851–59. http://dx.doi.org/10.2169/naika.101.2851.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Muravyev, Yu V., and A. S. Misiyuk. "Rheumatoid arthritis classification criteria: debatable problems." Rheumatology Science and Practice 56, no. 6 (2019): 805–7. http://dx.doi.org/10.14412/1995-4484-2018-805-807.

Full text
Abstract:
The paper discusses the issues of imperfect 1987 American College of Rheumatology (ACR) and the 2010 ACR/European League Against Rheumatology (EULAR) rheumatoid arthritis classification criteria and justifies the need for their correction.
APA, Harvard, Vancouver, ISO, and other styles
5

Fautrel, B., B. Combe, N. Rincheval, and M. Dougados. "Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data." Annals of the Rheumatic Diseases 71, no. 3 (2011): 386–89. http://dx.doi.org/10.1136/annrheumdis-2011-200259.

Full text
Abstract:
BackgroundIn 2010, new classification criteria for rheumatoid arthritis (RA) were developed.ObjectiveTo assess agreement between 1987 American College of Rheumatology (ACR) and 2010 ACR/European League Against Rheumatism (EULAR) criteria and the potential source of discordance, based on ESPOIR cohort data.Methods813 early arthritis patients were included in ESPOIR between 2002 and 2005. Between-criteria agreement was based on the κ coefficient. Discordance was explored by logistic regression.ResultsData for 811 patients were available, with their main characteristics as follows: women 77%, swollen joint count 7.2, tender joint count 8.4, disease activity score in 28 joints 5.2, rheumatoid factor 46%, anticitrullinated protein antibody (ACPA) 39%, structural damage 22%. At baseline, 579 (71.4%) patients met the 1987 ACR criteria and 641 (79.0%) the 2010 criteria. Agreement at baseline was discordant for 168 patients: 115 satisfied the 2010 criteria and 53 the 1987 criteria. Concordance between the two sets was fair, with a κ coefficient of 0.45 and 0.42 at baseline and year 2, respectively. The main sources of discordance were the number and symmetry of joint involvement, as well as ACPA status.Conclusion2010 ACR/EULAR criteria identified more patients with RA than did 1987 criteria. The 2010 criteria failed to identify RA patients with symmetrical seronegative arthritis and limited joint involvement.
APA, Harvard, Vancouver, ISO, and other styles
6

Cader, Mohammed Z., Andrew Filer, Jonathan Hazlehurst, Paola de Pablo, Christopher D. Buckley, and Karim Raza. "Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort." Annals of the Rheumatic Diseases 70, no. 6 (2011): 949–55. http://dx.doi.org/10.1136/ard.2010.143560.

Full text
Abstract:
ObjectiveEarly identification of patients with rheumatoid arthritis (RA) is essential to allow the prompt institution of therapy. The 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria, which replace the 1987 classification criteria, have been developed to facilitate such identification in patients with newly presenting inflammatory arthritis. This study therefore assesses the performance of these new criteria in patients with early synovitis.MethodsData were analysed from patients with synovitis seen within 3 months of the onset of inflammatory arthritis. Patients were followed for 18 months to determine outcomes, and data on the cumulative fulfilment of 2010 and 1987 criteria and therapy were recorded.Results265 patients were included in the study. 60 had alternative diagnoses at baseline. Of the remaining 205 patients, 20% fulfilled both 1987 and 2010 criteria, 3% fulfilled only 1987 criteria and 22% fulfilled only 2010 criteria at baseline. The 2010 criteria, when applied at baseline, detected more patients who eventually required disease-modifying antirheumatic drugs (DMARD) (65 (62%) vs 40 (38%); p<0.001), especially methotrexate (50 (68%) vs 31 (42%); p<0.01), within the first 18 months. However, more patients whose disease eventually resolved without ever requiring DMARD were classified at baseline as RA according to the 2010 criteria than with the 1987 criteria (16 (8%) vs 5 (2%); p=0.01).ConclusionThe 2010 ACR/EULAR criteria allow more rapid identification of patients requiring methotrexate compared with the 1987 ACR criteria when applied at baseline. However, overdiagnosis is an important issue to consider if these criteria are to be used in very early disease.
APA, Harvard, Vancouver, ISO, and other styles
7

Belakova, Gabriela, V. Manka, E. Zanova, and P. Racay. "Early Diagnosing and Treatment of Rheumatoid Arthritis, Benefits of Anti-Citrullinated Peptides Examination." Acta Medica Martiniana 17, no. 2 (2017): 28–31. http://dx.doi.org/10.1515/acm-2017-0009.

Full text
Abstract:
AbstractBackground: Anti-citrullinated peptides antibodies (ACPA) are specific for rheumatoid arthritis and have been implicated in disease pathogenesis. ACPA examination is a new component of ACR/EULAR 2010 classification criteria for rheumatoid arthritis. ACPA positivity predicts a more erosive disease course with severe joint damage and extra-articular manifestations. Objectives: To evaluate the benefits of ACPA examination in patients with early undifferentiated arthritis and patients with rheumatoid arthritis. Methods: We examined patients with arthritis and tested them for ACPA positivity. In every individual patient we evaluated if ACPA examination was necessary to establish the diagnosis of rheumatoid arthritis, or to change treatment, or if the diagnosis could have been established without ACPA examination (ACR/EULAR 2010 classification criteria was met without ACPA scoring). Results and Conclusions: We examined 833 patients with arthritis. There were 43 patients, or 62 % of a subgroup of 69 who were ACPA positive whose ACPA examination was not needed - ACR/EULAR criteria was met without ACPA scoring. This number represents 5.1 % of the total number examined. There were 15 patients, or 22 % of the subgroup and 1.8 % of the total whose diagnosis was revised to rheumatoid arthritis due to ACPA positivity - ACR/EULAR criteria was met solely with ACPA scoring. There were 11 patients (16 % and 1.3 %) whose medication was changed due to ACPA positivity. ACPA examination is useful in 3,1 % of all examined patients. When we correlate data on ACPA positive patients, 38 % of the patients profit from ACPA examinations. Considering the relatively low price of ACPA testing, this examination should not be excluded.
APA, Harvard, Vancouver, ISO, and other styles
8

Brinkmann, Gina H., Ellen S. Norli, Tore K. Kvien, et al. "Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study." Journal of Rheumatology 44, no. 2 (2017): 154–61. http://dx.doi.org/10.3899/jrheum.160693.

Full text
Abstract:
Objective.To examine the 2-year disease course in patients with undifferentiated arthritis (UA) focusing on fulfillment of the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) classification criteria.Methods.Data were provided by the Norwegian Very Early Arthritis Clinic study, which included patients presenting with ≥ 1 swollen joint of ≤ 16 weeks’ duration. UA was defined as patients not fulfilling the 2010 ACR/EULAR RA criteria and who did not have a clinical diagnosis other than RA at baseline. The main outcome was fulfillment of the 2010 RA criteria. Secondary outcomes were disease-modifying antirheumatic drug (DMARD) use, resolution of synovitis without use of DMARD during followup, and final clinical diagnosis.Results.We included 477 patients with UA of whom 47 fulfilled the 2010 ACR/EULAR RA criteria during followup (UA-RA) and 430 did not (UA–non-RA). Of the UA-RA patients, 70% fulfilled the criteria within the first 6 months. UA-RA patients were older, more often positive for rheumatoid factor and anticitrullinated protein antibodies, female, and ever smokers, and they more often presented with polyarticular arthritis, small joint involvement, and a swollen shoulder joint. During followup, 53% of UA-RA patients vs 13% of UA-non-RA patients used DMARD (p < 0.001). Overall, 71% of patients with UA achieved absence of clinical synovitis at final followup without use of DMARD. The most frequent final clinical diagnosis was UA (61%).Conclusion.Only 9.8% of patients with UA fulfilled the 2010 RA criteria during 2-year followup. Small joint involvement and swollen shoulder joint were among the factors associated with RA development. In two-thirds of patients with UA, the arthritis resolved without use of DMARD.
APA, Harvard, Vancouver, ISO, and other styles
9

TEHUPURING, SUKACITA, ARYATI, and LITA DIAH RAHMAWATI. "Profil Klinis dan Laboratorium Pasien Reumatoid Artritis Berdasarkan Kriteria Acr-Eular 2010 Di Poliklinik Reumatologi IRJ RSUD Dr.Soetomo Surabaya Tahun 2018." Hang Tuah Medical Journal 19, no. 2 (2022): 239–56. http://dx.doi.org/10.30649/htmj.v19i2.174.

Full text
Abstract:
Latar Belakang: Kriteria ACR-EULAR 2010 ditetapkan bertujuan untuk mendiagnosis Reumatoid Artritis (RA) lebih awal. Diharapkan hasil penelitian ini dapat memberikan bukti data profil pasien RA yang bisa dipakai secara nasional untuk menggambarkan perkembangan medis terkait RA. Profil yang dipilih adalah profil klinis dan laboratorium untuk merepresentasikan morbiditas, prognosis, dan perjalanan penyakit. Pasien dewasa dipilih untuk merepresentasikan dampak sosial ekonomi dan RSUD Dr. Soetomo dipilih sebagai sumber data untuk dapat merepresentasikan kasus RA di Indonesia Timur.
 Tujuan: Untuk mengetahui profil klinis dan laboratorium pasien RA berdasarkan kriteria ACR-EULAR 20210 di poliklinik Reumatologi IRJ RSUD Dr. Soetomo tahun 2018.
 Metode: Penelitian deskriptif-retrospektif menggunakan data rekam medis pasien RA di RSUD Dr. Soetomo.
 Hasil: 100% pasien dalam penelitian ini adalah wanita. Distribusi usia paling tinggi adalah 45-64 tahun 47,83%, 35-44 tahun 30.43%, 15-24 tahun 13,04%, 25-34 tahun 8,70% dengan median 43 tahun. Sebanyak 82,61% berpendidikan SMA dan 4,35% berpendidikan SMP dan 8,70% berpendidikan lebih rendah. 56,52% pasien berdomisili di luar Surabaya dan 43,44% pasien berdomisili di dalam kota Surabaya. 52,17% pasien terkena gejala RA pada 4–10 sendi keci, 13,04% pasien terkena pada lebih dari 10 sendi (minimal 1 sendi kecil) dan sebesar 17,39% pasien terkena pada 2–10 sendi besar dan 1–3 sendi kecil. 95,65% pasien menderita sakit 6 minggu atau lebih dan hanya 4,35% pasien yang sakitnya kurang dari 6 minggu. 65,22% pasien menunjukkan serologis RF positif. 91,30% pasien dengan anti-MCV positif. 95,65% pasien dengan LED di atas batas normal dengan median 55 mm/jam. 30,34% pasien menunjukkan CRP di atas batas normal, 26,09% pasien dengan CRP dalam batas normal sedangkan 43,48% pasien tidak ada data hasil pemeriksaan CRP. Evaluasi berdasarkan kriteria ACR-EULAR 2010 menunjukkan 43,48% pasien dengan skor 8; 26,09% pasien dengan skor 6; 4,35% pasien dengan skor 7; dan, 13.04% pasien dengan skor 9 dan dengan skor 10.
 Kesimpulan: Pasien Reumatoid Artritis di poliklinik Reumatologi IRJ RSUD Dr. Soetomo Surabaya tahun 2018 memiliki profil demografis lebih banyak berusia di atas 45 tahun, dengan tingkat pendidikan SMA, berasal dari luar kota Surabaya dan semuanya berjenis kelamin wanita; dengan profil klinis memiliki keterlibatan 4–10 sendi dengan lama sakit lebih dari 6 minggu; memiliki profil laboratorium dimana sebagian besar menunjukkan hasil serologis RF dan Anti-MCV yang positif, dengan angka LED di atas normal pada sebagian besar sampel; serta memiliki profil ACR-EULAR 2010 pada skor 8 dengan jumlah sampel terbesar dan pada skor 7 dengan jumlah sampel terkecil.
 Kata kunci: Reumatoid Artritis, ACR-EULAR 2010, RSUD Dr. Soetomo
APA, Harvard, Vancouver, ISO, and other styles
10

Morton, F., J. Nijjar, C. Goodyear, and D. Porter. "AB0210 ACREULAR: AN R PACKAGE FOR THE CALCULATION AND VISUALISATION OF ACR/EULAR RELATED RHEUMATOID ARTHRITIS MEASURES." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1405.1–1406. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2326.

Full text
Abstract:
Background:The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) individually and collaboratively have produced/recommended diagnostic classification, response and functional status criteria for a range of different rheumatic diseases. While there are a number of different resources available for performing these calculations individually, currently there are no tools available that we are aware of to easily calculate these values for whole patient cohorts.Objectives:To develop a new software tool, which will enable both data analysts and also researchers and clinicians without programming skills to calculate ACR/EULAR related measures for a number of different rheumatic diseases.Methods:Criteria that had been developed by ACR and/or EULAR that had been approved for the diagnostic classification, measurement of treatment response and functional status in patients with rheumatoid arthritis were identified. Methods were created using the R programming language to allow the calculation of these criteria, which were incorporated into an R package. Additionally, an R/Shiny web application was developed to enable the calculations to be performed via a web browser using data presented as CSV or Microsoft Excel files.Results:acreular is a freely available, open source R package (downloadable fromhttps://github.com/fragla/acreular) that facilitates the calculation of ACR/EULAR related RA measures for whole patient cohorts. Measures, such as the ACR/EULAR (2010) RA classification criteria, can be determined using precalculated values for each component (small/large joint counts, duration in days, normal/abnormal acute-phase reactants, negative/low/high serology classification) or by providing “raw” data (small/large joint counts, onset/assessment dates, ESR/CRP and CCP/RF laboratory values). Other measures, including EULAR response and ACR20/50/70 response, can also be calculated by providing the required information. The accompanying web application is included as part of the R package but is also externally hosted athttps://fragla.shinyapps.io/shiny-acreular. This enables researchers and clinicians without any programming skills to easily calculate these measures by uploading either a Microsoft Excel or CSV file containing their data. Furthermore, the web application allows the incorporation of additional study covariates, enabling the automatic calculation of multigroup comparative statistics and the visualisation of the data through a number of different plots, both of which can be downloaded.Figure 1.The Data tab following the upload of data. Criteria are calculated by the selecting the appropriate checkbox.Figure 2.A density plot of DAS28 scores grouped by ACR/EULAR 2010 RA classification. Statistical analysis has been performed and shows a significant difference in DAS28 score between the two groups.Conclusion:The acreular R package facilitates the easy calculation of ACR/EULAR RA related disease measures for whole patient cohorts. Calculations can be performed either from within R or by using the accompanying web application, which also enables the graphical visualisation of data and the calculation of comparative statistics. We plan to further develop the package by adding additional RA related criteria and by adding ACR/EULAR related measures for other rheumatic disorders.Disclosure of Interests:Fraser Morton: None declared, Jagtar Nijjar Shareholder of: GlaxoSmithKline plc, Consultant of: Janssen Pharmaceuticals UK, Employee of: GlaxoSmithKline plc, Paid instructor for: Janssen Pharmaceuticals UK, Speakers bureau: Janssen Pharmaceuticals UK, AbbVie, Carl Goodyear: None declared, Duncan Porter: None declared
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "2010 ACR/EULAR"

1

Peterfy, Charles, Philip G. Conaghan, and Mikkel Østergaard. "Radiography in rheumatoid arthritis." In Oxford Textbook of Rheumatoid Arthritis. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198831433.003.0017.

Full text
Abstract:
Medical imaging is used to determine whether structural damage (bone erosion and/or articular cartilage loss) is present in the patient with rheumatoid arthritis. Conventional radiography is inexpensive, widely available, and relatively safe, and characteristic radiographic findings are part of the American College of Rheumatology (ACR) 1987 classification criteria, as well as the ACR/European League Against Rheumatism (EULAR) 2010 classification. Radiography can be helpful in differentiating RA from other joint conditions, such as psoriatic arthritis, osteoarthritis, and neoplasm. This chapter discussion outlines the technical and interpretative principles, as well as the challenges, associated with radiographic evaluation of RA, and points to ways of dealing with some of the most common pitfalls in routine clinical practice and research.
APA, Harvard, Vancouver, ISO, and other styles
2

Gwinnutt, James, and Deborah Symmons. "The descriptive epidemiology of rheumatoid arthritis." In Oxford Textbook of Rheumatoid Arthritis. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198831433.003.0003.

Full text
Abstract:
This chapter describes the incidence, prevalence, and mortality of rheumatoid arthritis (RA) in adult populations around the world. Studies can only be compared if they have used the same case definition. The characteristics of the 1987 American College of Rheumatology (ACR) and the 2010 ACR/European League against Rheumatism (EULAR) classification criteria sets are discussed. In recent times several epidemiological studies have been set in large healthcare databases and have used physician diagnosis together with disease-modifying antirheumatic drugs (DMARD) prescription as the case definition. Most incidence and prevalence data on RA come from North America and Europe. Considerable insight into the relative frequency of RA has come from modelling studies in the Global Burden of Disease project 2010. The occurrence of RA is highest in the Pima and some other Native American groups; and lowest in low- and middle-income countries of Africa, South and East Asia, and the Middle East. The mortality of RA is increased relative to the general population. The mortality is falling with time, but in parallel with falls in the general population.
APA, Harvard, Vancouver, ISO, and other styles
3

Shiboski, Caroline H., and Troy E. Daniels. "Historical background, classification, and diagnostic criteria." In Oxford Textbook of Sjögren's Syndrome, edited by Elizabeth J. Price and Anwar R. Tappuni. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198806684.003.0002.

Full text
Abstract:
The objective of this chapter is to describe the evolution of, and critically assess, the various diagnostic and classification criteria for Sjögren’s syndrome (SS) first published in 1965. This chapter provides a historical perspective on the natural history of SS and the various diagnostic tests that have proven useful over time and are individual criteria items within the classification criteria set for SS most recently approved by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). We also summarize the guidelines and important steps recommended by the relevant ACR and EULAR committees for the development and validation of criteria for the rheumatic diseases. Finally, we describe the development and validation of the 2016 ACR-EULAR classification criteria for SS as part of a large international collaborative effort.
APA, Harvard, Vancouver, ISO, and other styles
4

Ambrosi, Aurélie, Albin Björk, and Marie Wahren-Herlenius. "Autoantibodies and autoantigens in Sjögren’s syndrome." In Oxford Textbook of Sjögren's Syndrome, edited by Elizabeth J. Price and Anwar R. Tappuni. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198806684.003.0005.

Full text
Abstract:
Autoantibodies are a key serological feature of Sjögren’s syndrome (SS). The presence of Ro/Sjögren’s syndrome-related antigen A (SSA) autoantibodies is one of the items with the highest weight in the 2016 joint ACR/EULAR SS classification criteria. Autoantibodies appear before overt clinical disease manifestations, and patient autoantibody profiles seem stable over time, even after B-cell depleting therapy. Expression of Ro/SSA and La/Sjögren’s syndrome-related antigen B (SSB), the major autoantigens in SS, in the target organs (exocrine glands), local autoantibody production, and the capacity of autoantigen-containing immune complexes to induce interferon production all point to a central involvement of autoantibodies in disease pathogenesis. Here, we review the main autoantibody specificities reported in SS, their clinical associations, the current understanding of how autoantibody production is initiated and maintained, and how autoantibodies may exert pathogenic effects. We provide a comprehensive overview of the nature and biological function of the three main autoantigens, Ro52, Ro60, and La (Ro/SSA and La/SSB) found in SS.
APA, Harvard, Vancouver, ISO, and other styles
5

Ng, Wan-Fai, Arjan Vissink, Elke Theander, and Francisco Figueiredo. "Sjögren’s syndrome—management." In Oxford Textbook of Rheumatology. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0128_update_003.

Full text
Abstract:
Management of Sjögren’s syndrome (SS) encompasses confirmation of diagnosis, disease assessment, and treatment of glandular and systemic manifestations including special situations such as pregnancy and SS-related lymphoma. The 2016 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria are the current gold standard for the diagnosis of SS. These criteria replace the 2002 American European Consensus Group (AECG) classification criteria. Salivary gland sialometry, sialochemistry, and ultrasound and tear osmolarity may be useful adjuncts. Symptoms of SS are non-specific and must be actively explored. When assessing patients with SS, it is important to consider not only objective parameters such as abnormalities in blood tests and changes in tear and salivary flow, but also patient-reported outcome measures and impact on quality of life. Current management of patients with SS is hampered by the lack of evidence-based strategies. The symptoms experienced by patients with SS are often not fully appreciated by clinicians, which may contribute to the suboptimal management of the condition. Management of fatigue remains a major challenge and a holistic, multidisciplinary approach is recommended. Factors that may contribute to fatigue should be fully addressed. Recent advances in the understanding of the pathogenic mechanisms of SS have informed more targeted therapeutic strategies with some promising data. Optimal management of SS requires expertise from different disciplines. Combined clinics with rheumatology, oral medicine, and ophthalmology input will improve care and communications as well as reduce the number of clinic visits for patients and healthcare-related cost. Effective link between pSS specialists, dentists, opticians, and general practitioners will facilitate early diagnosis and reduce risk of long-term disability of SS.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "2010 ACR/EULAR"

1

Hamdi, W., M. Sellami, H. Riahi, et al. "THU0180 Should we include ultrasound in the 1987 acr and 2010 acr/eular classification criteria for rheumatoid arthritis?" In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.5523.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nordberg, LB, S. Lillegraven, A.-B. Aga, et al. "FRI0151 Disease course in seronegative ra patients classified according to the 2010 acr/eular criteria." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4967.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ahmed, S., A. Aggarwal, and A. Lawrence. "THU0481 Validation of the proposed 2016 revision to 2010 acr preliminary fibromyalgia diagnostic criteria in a tertiray care setting." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2566.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Conijn, NFL, D. Lopes Barreto, TM Kuijper, et al. "AB1047 Can the acr/eular 2010 classification criteria be used as diagnostic tool for rheumatoid arthritis in real life?" In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.5790.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brinkmann, GH, ES Norli, P. Bøyesen, et al. "SAT0675 The role of erosions typical of rheumatoid arthritis in the 2010 acr/eular rheumatoid classification criteria: results from a very early arthritis cohort." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.1484.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Grignaschi, Silvia, Serena Bugatti, Francesca Benaglio, et al. "THU0079 AUTOANTIBODY-NEGATIVE PATIENTS, THE CUT-OFF OF SIX POINTS ACCORDING TO THE 2010 ACR/EULAR CRITERIA FOR RHEUMATOID ARTHRITIS MAY MISS A POPULATION OF SEVERE, PERSISTENT POLYARTHRITIS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Boeters, D., C. Gaujoux-Viala, A. Constantin, and A. van der Helm-van Mil. "FRI0131 The 2010 acr/eular criteria are insufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: results from the leiden-eac and espoir cohorts." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3994.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Boer, A. C., D. Boeters, and A. H. M. van der Helm – van Mil. "FRI0644 The use of mri-detected synovitis to determine the number of involved joints for the 2010 acr/eular classification criteria for rheumatoid arthritis – is it of additional benefit?" In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.4501.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Crisafulli, F., M. Y. Md Yusof, A. Aslam, et al. "AB1058 PERFORMANCE OF THE 2019 EULAR/ACR AND 2012 SLICC CLASSIFICATION CRITERIA FOR SLE AS DIAGNOSTIC CRITERIA." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.4350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Suda, M., H. Yanaoka, R. Rokutanda, et al. "SAT0447 Validation of the 2017 acr/eular classification criteria of systemic lupus erythematosus." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.5721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic '2010 ACR/EULAR' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography